Arcutis Biotherapeutics, Inc.ARQTNASDAQ
LOADING
|||
Cash Generation Expanding
Trending higher, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-112.30M
Near historical average
Average (7y)
$-123.84M
Historical baseline
Range
High:$-3.77M
Low:$-281.00M
CAGR
+62.4%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-112.30M | +54.6% |
| 2023 | $-247.49M | +11.9% |
| 2022 | $-281.00M | -60.0% |
| 2021 | $-175.62M | -54.9% |
| 2020 | $-113.35M | -162.8% |
| 2019 | $-43.13M | -206.2% |
| 2018 | $-14.09M | -273.1% |
| 2017 | $-3.77M | - |